Article
Long-read single-cell RNA sequencing enables the study of cancer subclone-specific genotypes and phenotypes in chronic lymphocytic leukemia.
Genome research - 14 Apr 2025
Black Gage S, Huang Xiaomeng, Qiao Yi, Moos Philip, Sampath Deepa, Stephens Deborah M, Woyach Jennifer A, Marth Gabor T
Abstract excerpt
Bruton tyrosine kinase (BTK) inhibitors are effective for the treatment of chronic lymphocytic leukemia (CLL) due to BTK's role in B cell survival and proliferation. Treatment resistance is most commonly caused by the emergence of the hallmark BTK C481S mutation that inhibits drug binding. In this study, we aimed to investigate cancer subclones harboring a BTK C481S mutation and identify cells with co-occurring...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
